ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

Clinical trial NCT07392723 · RECRUITING

Trial details

NCT number: NCT07392723
Sponsor: Michal Schnaider Beeri, Ph.D.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cognitive Dysfunction Alzheimer Disease Blood-Brain Barrier Apolipoprotein E, Deficiency or Defect of Brain Aging Fatty Acids, Omega-3

Start date: 2025-01-12
Primary completion: 2027-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.